Radek Gažák

Radek Gažák

Auto-generated profile, based on publicly available information

Radek Gažák

Laboratory of Antibiotic Resistance and Microbial Metabolomics, Institute of Microbiology, Czech Academy of Sciences, Vídeňská 1083, 142 00 Praha 4, Czech Republic

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 March 2018 in Natural Product Reports
Verified
Journal Article
Open access
PDF file
JJJ. Janata
J. Janata
ZKZ. Kamenik
Z. Kamenik
RGR. Gazak
R. Gazak
SKS. Kadlcik
S. Kadlcik
LNL. Najmanova
L. Najmanova
Covering: up to 2017 This review covers the biosynthetic and evolutionary aspects of lincosamide antibiotics, antitumour pyrrolobenzodiazepines (PBDs) and the quorum-sensing molecule hormaomycin. These structurally and functionally diverse groups of complex natural products all incorporate rarely occurring 4-alkyl-L-proline derivatives (APDs) biosynthesized from L-tyrosine through an unusual specialized pathway catalysed by a common set of six proteins named Apd1–Apd6. We give an overview of APD formation, which involves unusual enzyme activities, and its incorporation, which is based either on nonribosomal peptide synthetase (PBDs, hormaomycin) or a unique hybrid ergothioneine-dependent condensation system followed by mycothiol-dependent sulphur atom incorporation (lincosamides). Furthermore, within the public databases, we identified 36 novel unannotated biosynthetic gene clusters that putatively encode the biosynthesis of APD compounds. Their products presumably include novel PBDs, but also novel classes of APD compounds, indicating an unprecedented potential for the diversity enhancement of these functionally versatile complex metabolites. In addition, phylogenetic analysis of known and novel gene clusters for the biosynthesis of APD compounds allowed us to infer novel evolutionary hypotheses: Apd3 methyltransferase originates from a duplication event in a hormaomycin biosynthetic gene cluster ancestor, while putative Apd5 isomerase is evolutionarily linked to PhzF protein from the biosynthesis of phenazines. Lastly, we summarize the achievements in preparing hybrid APD compounds by directing their biosynthesis, and we propose that the number of nature-like APD compounds could by multiplied by replacing L-proline residues in various groups of complex metabolites with APD, i.e. by imitating the natural process that occurs with lincosamides and PBDs, in which the replacement of L-proline for APD has proved to be an evolutionary successful concept.

14 August 2015 in Journal of Natural Products
Verified
Journal Article
Closed access
VVVladimir Vimberg
Vladimir Vimberg
MKMarek Kuzma
Marek Kuzma
ESEva Stodůlková
Eva Stodůlková
Petr NovakPetr Novak
Petr Novak
LBLucie Bednárová
Lucie Bednárová
RGRadek Gažák
Radek Gažák

22 November 2024 in Organic & Biomolecular Chemistry
Verified
Journal Article
Open access
PDF file
KDKateřIna Delawská
KateřIna Delawská
JHJan Hájek
Jan Hájek
KVKateřIna Voráčová
KateřIna Voráčová
MKMarek Kuzma
Marek Kuzma
JMJan Mares
Jan Mares
PHPavel Hrouzek
Pavel Hrouzek
Nostatin A is highly modified ribosomally synthesized and post-translationally modified peptide belonging among proteusins. It inhibits multiple cancer cell lines in nanomolar concentrations and acts via cell cycle arrest and subsequent apoptosis.